Deficiencies: Deficiencies of vanadium are unknown in humans. In rats, chicks and goats, a variety of inconsistent deficiency symptoms have been seen but only under conditions of synthetic diets with all vanadium excluded. Signs include reduced growth, poor bone development, impaired reproductive capacity and, in chicks, poor feather development.
Diet recommendations: The Estimated Safe and Adequate Daily Dietary Intake is about 100 µg/day. No clear role of vanadium has been established in humans. Bioavailability is very low, usually found to be less than 1% of an administered dose. Thus, most ingested vanadium is excreted unabsorbed. The best food sources include parsley, black pepper, dill, mushrooms and shellfish. Fresh fruits, legumes and dairy products usually contain very low levels of vanadium; however, processing (e.g., to produce dried milk powder or canned apple juice) increases vanadium levels.
Clinical uses: Both vanadyl sulfate and sodium metavanadate are being tested as anti-diabetic agents in clinical trials; however, there are as yet no vanadium compounds in routine clinical use. Vanadium is sometimes used informally by body builders; however, this practice is without scientific backing or verifiable evidence of a positive effect.
Toxicity: Vanadium is generally more toxic when inhaled than when taken orally. Toxic levels vary considerably, depending on the age and species of animals, and on other components of the diet such as protein content and other trace elements. Humans have taken quite large doses (up to 25 mg vanadium/day for adult males) in experimental settings for up to 5 months. There were only minor complaints (green tongue, GI upset) at the higher doses. In experimental animals toxicity symptoms include dehydration, weight loss, depressed growth, diarrhea, breathing difficulties, cardiac irregularities and loss of renal function. The LD50 for rats has been determined as 0.8 mmol/kg (approximately 50 mg as sodium metavanadate),
Recent research: The relationship between vanadium intake and thyroid metabolism and the glucose-lowering effect of orally administered vanadium are two topics of current research interest.
For further information:
Harland, B. F. & Harden-Williams, B. A. (1994) Is vanadium of human nutritional importance yet? J. Am. Diet. Assoc. 94: 891-894.
French, R. J. & Jones, P. J. H. (1992) Role of vanadium in nutrition: metabolism, essentiality and dietary considerations. Life Sci. 52: 339-346.
Thompson, K. H., Yuen, V. G., McNeill, J. H. & Orvig, C. (1998) Chemical and pharmacological studies of a new class of antidiabetic vanadium compounds. In: Vanadium Compounds. Chemistry, Biochemistry, and Therapeutic Applications (Tracey, A. C. & Crans, D. C., eds.), ACS Symposium Series, vol. 711, pp. 329-343. American Chemical Society, New York, NY.
Prepared By:
Joseph Leichter, Ph.D.
Professor of Nutrition
Division of Human Nutrition
University of British Columbia
2205 E Mall
Vancouver, British Columbia, Canada V6T 1Z4
Phone: 604-822-3111
FAX: 604-822-5143
Email: leichter@unixg.ubc.ca
Katherine Thompson, Ph.D.
Chemistry Department
University of British Columbia
2036 Main Mall
Vancouver, British Columbia
Canada, V6T 1Z1
Phone: 604-822-1776
FAX: 604-822-2847
Email: kthompso@chem.ubc.ca